doi: 10.1097/01.coc.0000275493.95395.60
Gaui M de F, Amorim G, Arcuri RA, Pereira G, Moreira D, Djahjah C, Biasoli I, Spector N. A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer. Am J Clin Oncol . 2007;30(1):78–81.
On p78 in the abstract, under Patients and Methods, the last sentence should read: “Patients received radiation therapy (total dose 5000 cGy) and concomitant capecitabine (850 mg/m2 ) twice daily for 14 days every 3 weeks.”
On p79, in the Study Design section, the second sentence should read: “The total radiation dose was 5000 cGy given over 5 weeks (200 cGy/day for 5 days per week).”
The journal regrets this mistake.
© 2007 Lippincott Williams & Wilkins, Inc. View full article text 
